SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-21-000055
Filing Date
2021-11-05
Accepted
2021-11-05 17:08:38
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alim-20210930x10q.htm   iXBRL 10-Q 4295594
2 EX-10.7.H alim-20210930xex10_7h.htm EX-10.7.H 97241
3 EX-31.1 alim-20210930xex31_1.htm EX-31.1 20941
4 EX-31.2 alim-20210930xex31_2.htm EX-31.2 21158
5 EX-32.1 alim-20210930xex32_1.htm EX-32.1 16065
  Complete submission text file 0001267602-21-000055.txt   14285593

Data Files

Seq Description Document Type Size
6 EX-101.SCH alim-20210930.xsd EX-101.SCH 51539
7 EX-101.CAL alim-20210930_cal.xml EX-101.CAL 64470
8 EX-101.DEF alim-20210930_def.xml EX-101.DEF 235849
9 EX-101.LAB alim-20210930_lab.xml EX-101.LAB 507555
10 EX-101.PRE alim-20210930_pre.xml EX-101.PRE 391217
11 EXTRACTED XBRL INSTANCE DOCUMENT alim-20210930x10q_htm.xml XML 3452421
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 211385494
SIC: 2834 Pharmaceutical Preparations